Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

...

199

الكل

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
N05AX12	ATYPRAL	G	Aripiprazole - 10mg	10mg	Tablet	712,237 L.L
N05AX12	ATYPRAL	G	Aripiprazole - 15mg	15mg	Tablet	712,237 L.L
L04AA31	AUBAGIO	B	Teriflunomide - 14mg	14mg	Tablet, film coated	1,110,589 L.L
L04AA31	AUBAGIO	B	Teriflunomide - 14mg	14mg	Tablet, film coated	67,708,769 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 125mg/5ml, Clavulanic Acid (potassium) - 31.25mg/5ml	156.25mg/5ml	Powder for suspension	302,365 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 125mg/5ml, Clavulanic Acid (potassium) - 31.25mg/5ml	156.25mg/5ml	Powder for suspension	302,365 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 250mg/5ml, Clavulanic Acid (potassium) - 62.5mg/5ml	312.5mg/5ml	Powder for suspension	542,912 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 250mg/5ml, Clavulanic Acid (potassium) - 62.5mg/5ml	312.5mg/5ml	Powder for suspension	542,912 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 400mg/5ml, Clavulanic Acid (potassium) - 57mg/5ml	457mg/5ml	Powder for suspension	524,099 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 400mg/5ml, Clavulanic Acid (potassium) - 57mg/5ml	457mg/5ml	Powder for suspension	524,099 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 250mg, Clavulanic Acid (potassium) - 125mg	375mg	Tablet, film coated	490,503 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 500mg, Clavulanic Acid (potassium) - 125mg	625mg	Tablet	466,459 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 875mg, Clavulanic Acid (potassium) - 125mg	1g	Tablet	625,185 L.L
J01CR02	AUGMENTIN ES	B	Amoxicillin (trihydrate) - 600mg/5ml, Clavulanic Acid (potassium) - 42.9mg/5ml	642.9mg/5ml	Powder for suspension	1,513,167 L.L
S02CA06	AURICULARUM	G	Dexamethasone (sodium phosphate) - 10mg, Nystatin - 1,000,000IU, Oxytetracycline HCl - 90,000IU, Polymyxin B sulfate - 100,000IU		Powder for suspension + solvent	755,239 L.L
R01BA53	AURIMEL	B	Phenylephrine HCl - 5mg/5ml, Sodium citrate - 325mg/5ml, Carbinoxamine maleate - 2mg/5ml, Dextromethorphan HBr - 5mg/5ml		Syrup	319,963 L.L
D06AX09	AVALON AVOBAN	G	Mupirocin - 2% w/w	2%	Ointment	460,938 L.L
J01MA14	AVALOX	B	Moxifloxacin (HCl) - 400mg	400mg	Tablet, film coated	1,087,169 L.L
J01MA14	AVALOX	B	Moxifloxacin (HCl) - 400mg	400mg	Tablet, film coated	1,521,230 L.L
J01MA14	AVALOX	B	Moxifloxacin (HCl) - 400mg/250ml	400mg/250ml	Injectable solution	9,052,935 L.L
R01AD12	AVAMYS	B	Fluticasone furoate - 27.5mcg/dose	27.5mcg/dose	Suspension	722,987 L.L
R01AD12	AVAMYS	B	Fluticasone furoate - 27.5mcg/dose	27.5mcg/dose	Suspension	722,987 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrated solution	75,875,312 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 400mg	400mg	Injectable concentrated solution	75,875,312 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrated solution	24,533,456 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 100mg	100mg	Injectable concentrated solution	24,533,456 L.L
J07BC02	AVAXIM PEDIATRIQUE (vaccin inactivé de l'hépatite A adsorbé)	B	Hepatitis A, inactivated, whole virus - 80 antigen units/0.5ml	80 antigen units/0.5ml	Injectable suspension	1,531,980 L.L
J05AX27	AVIPIRAVIR	B	Favipiravir - 200mg	200mg	Tablet, film coated	4,339,267 L.L
J05AF10	AVIRAVIR	G	Entecavir monohydrate - 1mg	1mg	Tablet, film coated	13,447,765 L.L
J05AF10	AVIRAVIR	G	Entecavir monohydrate - 0.5mg	0.5mg	Tablet, film coated	13,447,765 L.L

...

199